Diuretic treatment in those dying from a myocardial infarction

Clare Battersby, Margot Daymond, William M. Styles, Allan D. Struthers, David Rowley-Jones, Christopher J. Bulpitt

    Research output: Contribution to journalArticle

    Abstract

    The relative risk of dying from a myocardial infarction according to diuretic therapy was estimated in a case control study for 189 cases, 144 dead controls and 349 living controls. The controls were matched for age (±2.5 years), sex and general practice. The study was community-based; the cases were identified from death certificates and the death certificates of the dead controls had no mention of ischaemic heart disease. The relative risk was estimated from the odds ratio and was similar whether dead or living controls were considered. Against all controls combined, the odds ratio for dying while taking a potassium-losing diuretic at 1 month prior to death (R1) was 1.5 (95 per cent CI 0.9, 2.4) and for a combined potassium-losing + sparing diuretic (RL+S) was 2.0 (95 per cent CI 1.1, 3.4). Potassium-sparing diuretics may be given more frequently to patients at greater risk of dying, thus masking a benefit, but the data could not provide evidence for a benefit from the addition of a potassium-sparing diuretic.

    Original languageEnglish
    Pages (from-to)81-85
    Number of pages5
    JournalPharmacoepidemiology and Drug Safety
    Volume1
    Issue number2
    DOIs
    Publication statusPublished - 1992

    Fingerprint

    Potassium Sparing Diuretics
    Diuretics
    Death Certificates
    Myocardial Infarction
    Odds Ratio
    General Practice
    Myocardial Ischemia
    Case-Control Studies
    Potassium
    Therapeutics

    Keywords

    • Myocardial infarction
    • Diuretic

    Cite this

    Battersby, C., Daymond, M., Styles, W. M., Struthers, A. D., Rowley-Jones, D., & Bulpitt, C. J. (1992). Diuretic treatment in those dying from a myocardial infarction. Pharmacoepidemiology and Drug Safety, 1(2), 81-85. https://doi.org/10.1002/pds.2630010206
    Battersby, Clare ; Daymond, Margot ; Styles, William M. ; Struthers, Allan D. ; Rowley-Jones, David ; Bulpitt, Christopher J. / Diuretic treatment in those dying from a myocardial infarction. In: Pharmacoepidemiology and Drug Safety. 1992 ; Vol. 1, No. 2. pp. 81-85.
    @article{1d6cc09ee4f24441a027c102933e9670,
    title = "Diuretic treatment in those dying from a myocardial infarction",
    abstract = "The relative risk of dying from a myocardial infarction according to diuretic therapy was estimated in a case control study for 189 cases, 144 dead controls and 349 living controls. The controls were matched for age (±2.5 years), sex and general practice. The study was community-based; the cases were identified from death certificates and the death certificates of the dead controls had no mention of ischaemic heart disease. The relative risk was estimated from the odds ratio and was similar whether dead or living controls were considered. Against all controls combined, the odds ratio for dying while taking a potassium-losing diuretic at 1 month prior to death (R1) was 1.5 (95 per cent CI 0.9, 2.4) and for a combined potassium-losing + sparing diuretic (RL+S) was 2.0 (95 per cent CI 1.1, 3.4). Potassium-sparing diuretics may be given more frequently to patients at greater risk of dying, thus masking a benefit, but the data could not provide evidence for a benefit from the addition of a potassium-sparing diuretic.",
    keywords = "Myocardial infarction, Diuretic",
    author = "Clare Battersby and Margot Daymond and Styles, {William M.} and Struthers, {Allan D.} and David Rowley-Jones and Bulpitt, {Christopher J.}",
    year = "1992",
    doi = "10.1002/pds.2630010206",
    language = "English",
    volume = "1",
    pages = "81--85",
    journal = "Pharmacoepidemiology and Drug Safety",
    issn = "1053-8569",
    publisher = "Wiley",
    number = "2",

    }

    Battersby, C, Daymond, M, Styles, WM, Struthers, AD, Rowley-Jones, D & Bulpitt, CJ 1992, 'Diuretic treatment in those dying from a myocardial infarction', Pharmacoepidemiology and Drug Safety, vol. 1, no. 2, pp. 81-85. https://doi.org/10.1002/pds.2630010206

    Diuretic treatment in those dying from a myocardial infarction. / Battersby, Clare; Daymond, Margot; Styles, William M.; Struthers, Allan D.; Rowley-Jones, David; Bulpitt, Christopher J.

    In: Pharmacoepidemiology and Drug Safety, Vol. 1, No. 2, 1992, p. 81-85.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Diuretic treatment in those dying from a myocardial infarction

    AU - Battersby, Clare

    AU - Daymond, Margot

    AU - Styles, William M.

    AU - Struthers, Allan D.

    AU - Rowley-Jones, David

    AU - Bulpitt, Christopher J.

    PY - 1992

    Y1 - 1992

    N2 - The relative risk of dying from a myocardial infarction according to diuretic therapy was estimated in a case control study for 189 cases, 144 dead controls and 349 living controls. The controls were matched for age (±2.5 years), sex and general practice. The study was community-based; the cases were identified from death certificates and the death certificates of the dead controls had no mention of ischaemic heart disease. The relative risk was estimated from the odds ratio and was similar whether dead or living controls were considered. Against all controls combined, the odds ratio for dying while taking a potassium-losing diuretic at 1 month prior to death (R1) was 1.5 (95 per cent CI 0.9, 2.4) and for a combined potassium-losing + sparing diuretic (RL+S) was 2.0 (95 per cent CI 1.1, 3.4). Potassium-sparing diuretics may be given more frequently to patients at greater risk of dying, thus masking a benefit, but the data could not provide evidence for a benefit from the addition of a potassium-sparing diuretic.

    AB - The relative risk of dying from a myocardial infarction according to diuretic therapy was estimated in a case control study for 189 cases, 144 dead controls and 349 living controls. The controls were matched for age (±2.5 years), sex and general practice. The study was community-based; the cases were identified from death certificates and the death certificates of the dead controls had no mention of ischaemic heart disease. The relative risk was estimated from the odds ratio and was similar whether dead or living controls were considered. Against all controls combined, the odds ratio for dying while taking a potassium-losing diuretic at 1 month prior to death (R1) was 1.5 (95 per cent CI 0.9, 2.4) and for a combined potassium-losing + sparing diuretic (RL+S) was 2.0 (95 per cent CI 1.1, 3.4). Potassium-sparing diuretics may be given more frequently to patients at greater risk of dying, thus masking a benefit, but the data could not provide evidence for a benefit from the addition of a potassium-sparing diuretic.

    KW - Myocardial infarction

    KW - Diuretic

    U2 - 10.1002/pds.2630010206

    DO - 10.1002/pds.2630010206

    M3 - Article

    VL - 1

    SP - 81

    EP - 85

    JO - Pharmacoepidemiology and Drug Safety

    JF - Pharmacoepidemiology and Drug Safety

    SN - 1053-8569

    IS - 2

    ER -